Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions

Biochem Biophys Res Commun. 1992 May 29;185(1):85-90. doi: 10.1016/s0006-291x(05)80958-1.

Abstract

Several aurintricarboxylic acid (ATA) monomers, monomer analogs, and polymer fractions have been tested as inhibitors of HIV-1 integration protein (IN). Both of the ATA monomers and all of the ATA polymer fractions inhibited a selective DNA cleavage reaction catalyzed by IN. The ATA monomer analogs were inactive or had low activity. The activities of the substances as inhibitors of HIV IN correlated in a positive way with their activities as inhibitors of the cytopathic effect of HIV-1 in CEM and HIV-2 in MT4 cells. These results suggest that inhibition of HIV IN may contribute to the antiviral activity of the ATA monomers and monomer analogs in cell culture.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / pathology
  • Aurintricarboxylic Acid / analogs & derivatives
  • Aurintricarboxylic Acid / pharmacology*
  • Cells, Cultured
  • DNA Nucleotidyltransferases / drug effects*
  • HIV / drug effects*
  • HIV / pathogenicity
  • HIV-1 / drug effects
  • HIV-1 / pathogenicity
  • HIV-2 / drug effects
  • HIV-2 / pathogenicity
  • Humans
  • Integrases
  • Polymers / pharmacology
  • Retroviridae Proteins / drug effects*
  • Virus Integration / drug effects

Substances

  • Polymers
  • Retroviridae Proteins
  • Aurintricarboxylic Acid
  • DNA Nucleotidyltransferases
  • Integrases